Search

Oxford Science Park based Sitryx aims to be a leader immunometabolism - a deal with Lilly has been validating
CEO Iain Kilty describes the keys to intervening in cell metabolism, and discusses pipeline assets such as a PKM2 for atopic dermatitis...
Sep 17, 2024